IL145507A0 - Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin to its high affinity receptor - Google Patents

Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin to its high affinity receptor

Info

Publication number
IL145507A0
IL145507A0 IL14550700A IL14550700A IL145507A0 IL 145507 A0 IL145507 A0 IL 145507A0 IL 14550700 A IL14550700 A IL 14550700A IL 14550700 A IL14550700 A IL 14550700A IL 145507 A0 IL145507 A0 IL 145507A0
Authority
IL
Israel
Prior art keywords
immunoglobulin
inhibit
binding
high affinity
affinity receptor
Prior art date
Application number
IL14550700A
Other languages
English (en)
Original Assignee
Novartis Ag
Patent & Trademark Dept
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Patent & Trademark Dept filed Critical Novartis Ag
Publication of IL145507A0 publication Critical patent/IL145507A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14550700A 1999-04-14 2000-04-12 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin to its high affinity receptor IL145507A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds
PCT/EP2000/003288 WO2000063252A1 (en) 1999-04-14 2000-04-12 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor

Publications (1)

Publication Number Publication Date
IL145507A0 true IL145507A0 (en) 2002-06-30

Family

ID=10851525

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14550700A IL145507A0 (en) 1999-04-14 2000-04-12 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin to its high affinity receptor
IL145507A IL145507A (en) 1999-04-14 2001-09-17 Anti-idiotypic antibodies against antibodies that inhibit the binding of immunoglobulin to our high affinity receptor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145507A IL145507A (en) 1999-04-14 2001-09-17 Anti-idiotypic antibodies against antibodies that inhibit the binding of immunoglobulin to our high affinity receptor

Country Status (29)

Country Link
US (1) US7041288B2 (ja)
EP (1) EP1169353B1 (ja)
JP (1) JP4109829B2 (ja)
KR (1) KR100492202B1 (ja)
CN (1) CN1268644C (ja)
AR (1) AR029624A1 (ja)
AT (1) ATE392437T1 (ja)
AU (1) AU767712B2 (ja)
BR (1) BR0009781A (ja)
CA (1) CA2363991C (ja)
CO (1) CO5241329A1 (ja)
CZ (1) CZ20013673A3 (ja)
DE (1) DE60038608T2 (ja)
ES (1) ES2302693T3 (ja)
GB (1) GB9908533D0 (ja)
HK (1) HK1044544B (ja)
HU (1) HUP0200713A2 (ja)
IL (2) IL145507A0 (ja)
MX (1) MXPA01010348A (ja)
MY (1) MY141459A (ja)
NO (1) NO20014936L (ja)
PE (1) PE20010046A1 (ja)
PL (1) PL350676A1 (ja)
PT (1) PT1169353E (ja)
RU (1) RU2253655C2 (ja)
SK (1) SK14592001A3 (ja)
TR (1) TR200102877T2 (ja)
WO (1) WO2000063252A1 (ja)
ZA (1) ZA200107906B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
EP1497654A4 (en) 2001-08-13 2006-06-07 Chen Swey Shen Alex IMMUNOGLOBULIN E VACCINES AND METHODS OF USE
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
US7718772B2 (en) * 2006-12-14 2010-05-18 Schering-Plough Animal Health Corporation Canine thymic stromal lymphopoietin protein and uses thereof
EP2473605B1 (en) * 2009-09-03 2018-04-11 Pfizer Vaccines LLC Pcsk9 vaccine
SG178991A1 (en) * 2009-09-03 2012-04-27 Schering Corp Anti-gitr antibodies
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
BR112021016791A2 (pt) * 2019-02-26 2021-11-16 Sorrento Therapeutics Inc Proteínas de ligação de antígenos que se ligam a bcma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ATE45285T1 (de) 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
DE122006000007I1 (de) * 1987-12-31 2006-04-27 Tanox Biosystems Inc Antigene epitope, die sich ausschlisslich auf ige-tragenden B-Lymphocyten befinden.
JP3449712B2 (ja) 1990-01-23 2003-09-22 タノックス バイオシステムズ インコーポレイテッド ヒトε免疫グロブリン固定ペプチドの細胞外部分及びそれに特異的な抗体
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
JPH08502260A (ja) 1992-09-30 1996-03-12 ザ スクリップス リサーチ インスティテュート ヒト免疫不全ウイルスに対するヒト中和モノクローナル抗体
RU2193413C2 (ru) * 1996-03-01 2002-11-27 Новартис Аг Пептидные иммуногены для вакцинации и лечения аллергии
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
CA2350163A1 (en) 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)

Also Published As

Publication number Publication date
IL145507A (en) 2008-11-03
PE20010046A1 (es) 2001-02-23
EP1169353A1 (en) 2002-01-09
MXPA01010348A (es) 2002-10-23
CN1268644C (zh) 2006-08-09
AR029624A1 (es) 2003-07-10
EP1169353B1 (en) 2008-04-16
AU767712B2 (en) 2003-11-20
NO20014936L (no) 2001-12-03
NO20014936D0 (no) 2001-10-10
PT1169353E (pt) 2008-07-14
AU3966000A (en) 2000-11-02
HUP0200713A2 (en) 2002-07-29
ES2302693T3 (es) 2008-08-01
TR200102877T2 (tr) 2002-01-21
US7041288B2 (en) 2006-05-09
SK14592001A3 (sk) 2002-05-09
JP2002544125A (ja) 2002-12-24
RU2253655C2 (ru) 2005-06-10
BR0009781A (pt) 2002-01-08
DE60038608D1 (de) 2008-05-29
US20020141989A1 (en) 2002-10-03
CO5241329A1 (es) 2003-01-31
ATE392437T1 (de) 2008-05-15
CN1346372A (zh) 2002-04-24
CA2363991A1 (en) 2000-10-26
HK1044544A1 (en) 2002-10-25
CA2363991C (en) 2010-06-08
PL350676A1 (en) 2003-01-27
KR20020007366A (ko) 2002-01-26
CZ20013673A3 (cs) 2002-05-15
JP4109829B2 (ja) 2008-07-02
DE60038608T2 (de) 2009-06-10
GB9908533D0 (en) 1999-06-09
WO2000063252A1 (en) 2000-10-26
KR100492202B1 (ko) 2005-06-03
MY141459A (en) 2010-04-30
HK1044544B (zh) 2008-11-21
ZA200107906B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
IL175399A (en) Antibodies binding to ob receptor variants
IL145507A0 (en) Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin to its high affinity receptor
EP1169352A4 (en) ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
EP1465925A4 (en) "ANTIBODIES THAT IMMUNE SPECIFICALLY TO TRAIL RECEPTORS"
HK1075470A1 (en) Antibodies that immunospecifically bind to trail receptors
IL229857A0 (en) 1rp7b mature polypeptide binding antibody
DK0906784T3 (da) Fremgangsmåde til fremstilling af bundne zeolitter
HK1086598A1 (en) Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
EP1572874A3 (en) Antibodies that immunospecifically bind to trail receptors
EP1117438A4 (en) ANTAGONIST ANTIBODIES OF TIE2
IL162588A0 (en) Lyophilized preparation containing antibodies to the egf receptor
HK1077063A1 (en) Triazospiro compounds having nociceptin receptor affinity
PL335100A1 (en) Oxazolynones as antagonists of 5ht2a receptor
EP1218413A4 (en) IRREVERSIBLE BINDING ANTIBODY MANIPULATIONS
EP1044194A4 (en) RECEPTOR HAVING AN AFFINITY FOR OXAZOLINE CATEGORY COMPOUNDS
PL338453A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
IL148266A0 (en) Apo-2 receptor antibodies
IL143783A (en) Intermediates for the preparation of eprosartan
AU2002352676A1 (en) Antibodies that immunospecifically bind to trail receptors
AU7099900A (en) Peptides that bind to urokinase receptor
PL338456A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
EP1086119A4 (en) PURIFICATION OF ANTIBODIES
GB9718911D0 (en) Monoclonal antibodies
GB9712410D0 (en) Peptides and compounds that bind to the il-5 receptor
IL126245A0 (en) Antibodies to ifn-beta2/il-6 receptor